Very common side effects (more than 1 in 5)
Fatigue
The most universal side effect. Usually mild to moderate, lasting 3–7 days after each cycle, occasionally lingering longer. Cumulative fatigue is uncommon. Adequate rest, hydration, and light exercise help.
Dry mouth (Lu-177 PSMA therapy)
Salivary glands also express PSMA at low levels and pick up some medicine. Usually mild to moderate, persistent in a minority. Management: sugar-free gum/candy, hydration, humidifier, saliva substitutes, careful dental care.
Nausea
More common with Lu-177 DOTATATE therapy (often from the amino acid infusion). Usually well controlled with pre-medication anti-emetics. Severe nausea is uncommon.
Mild blood count changes
Bone marrow is exposed to some radiation. Hemoglobin, platelets, and white cells often dip 2–4 weeks post-cycle. Most dips are mild and recover before the next cycle. Pre-cycle blood tests catch this.
Common side effects (5–20%)
- Mild abdominal discomfort — particularly with NETs treatment
- Decreased appetite — usually transient
- Constipation or diarrhea — manageable with diet and OTC medications
- Back or bone pain — sometimes due to tumor flare (actually a sign of response)
- Headache — usually mild
- Mild allergic reactions — usually responsive to anti-histamines
- Worsened carcinoid symptoms (Lu-177 DOTATATE therapy) — temporary flushing or diarrhea after early cycles
Rare but serious side effects
How Lutetium therapy compares to chemotherapy
For most patients, Lutetium therapy is much easier to tolerate than chemotherapy:
- No hair loss (vs near-universal hair loss with most chemo)
- Milder nausea, much less severe vomiting
- Better preserved energy
- Less interference with daily life
- Better preserved blood counts in most cases
- No long-term peripheral neuropathy
This quality-of-life advantage is a major reason patients and oncologists are increasingly choosing Lutetium therapy earlier in the disease course.
Frequently asked questions
What's the worst side effect most patients experience?
For Lu-177 PSMA therapy: persistent dry mouth in some patients. For Lu-177 DOTATATE therapy: nausea during the amino acid infusion. Severe issues are uncommon for both.
Will I lose weight?
Some patients lose mild weight due to decreased appetite. Many actually gain weight as their cancer responds and they feel better. Significant weight loss is unusual and should be discussed with your team.
Can I work during treatment?
Most patients continue working at least part-time. The 3–7 days after each cycle may require lighter activity. Plan time off around cycle days if your work is physical.
Will side effects get worse with each cycle?
Most patients don't see cumulative worsening. Blood counts may dip slightly more with each cycle but usually recover. Fatigue often improves as the cancer responds.
What about long-term effects?
The biggest long-term concerns are persistent low blood counts (in a few patients) and rare secondary cancers. Kidney function is monitored long-term. Most patients have no significant long-term effects.